Literature DB >> 26242669

Kaposi's sarcoma, a South African perspective: Demographic and pathological features.

Reena Dhansukh Mohanlal1, Sugeshnee Pather.   

Abstract

BACKGROUND: The incidence of Kaposi's sarcoma (KS) has increased dramatically since the onset of the AIDS epidemic. Of the estimated 66 200 cases of KS worldwide, 58 800 are considered to have occurred in sub-Saharan Africa.
OBJECTIVES: To describe the epidemiology and pathological characteristics of KS at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
METHODS: A retrospective cross-sectional study design was used. Nine hundred and thirty-eight histopathology reports of KS diagnosed in 901 patients at CHBAH between 2005 and 2009 were reviewed. Age, gender, topographic site, CD4 count, HIV status, KS histological stage, findings of human herpesvirus 8 latency-associated nuclear antigen 1 immunohistochemistry and concomitant pathological findings were recorded.
RESULTS: The male/female ratio was 1.2:1, the mean age 37 years and the median CD4 count 128 cells/µL. Lower limb skin biopsies accounted for 49.6% of cases. Paediatric, visceral and endemic KS accounted for only limited proportions (1.4%, 1.4% and 1.3% of biopsies, respectively). There were concomitant pathological findings in 4.6% of biopsy specimens, infections and inflammatory dermatoses being the most frequent.
CONCLUSION: The findings of this study highlight the need for allocation of diagnostic and treatment resources for KS. Documentation of the various demographic aspects of KS will prove to be of historical, clinical and histopathological interest as the long-term outcomes of antiretroviral therapy begin to emerge.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26242669     DOI: 10.7196/samj.8773

Source DB:  PubMed          Journal:  S Afr Med J


  2 in total

1.  A retrospective review of patients with Kaposi's sarcoma in Botswana.

Authors:  Christa Slaught; Victoria Williams; Surbhi Grover; Elizabeth Bigger; Mukendi Kayembe; Sebathu Chiyapo; Nicholas J Jackson; Scott Dryden-Peterson; Carrie L Kovarik; Karolyn A Wanat
Journal:  Int J Dermatol       Date:  2018-11-21       Impact factor: 3.204

Review 2.  Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.

Authors:  Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.